Rectal Cancer

Overview

No Reviews

Credits

1.25

Post Assesment Questions

7

Release Date

5 Oct 2020

Expiration Date

17 Dec 2021

Last Reviewed

17 Dec 2020

Estimated Time To Finish

75 Minutes

Stay up to date on the latest medical knowledge

Start This Activity
 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Colon and rectal cancers together are the third most commonly diagnosed cancer in the United States and the second deadliest. Rectal cancer has distinct environmental associations and genetic risk factors different from colon cancer. The incidence of new cases and mortality of rectal cancer has been steadily declining for the past years, although noticed to rise in recent years on younger adults (less than 50 years). The transformation of the normal rectal epithelium to a dysplastic lesion and eventually an invasive carcinoma requires an accumulation of genetic mutations either somatic (acquired) and/or germline (inherited) over an approximately 10 to 15 years period. Tumor regression grade after pre-operative therapy and pathological staging are the most important prognostic indicators of rectal cancer. All newly diagnosed patients with rectal cancer should be universally screened for DNA mismatch repair/microsatellite status present in up to 13% of all sporadic rectal cancer cases. A careful history and physical examination, including a digital rectal exam, are paramount on clinical suspicion. An endoscopy examination with rigid sigmoidoscopy is required to measure the distance from the lesion to the anal verge (less than 15 cm) and for tissue biopsy for pathological confirmation of rectal cancer. This activity reviews the cause, pathophysiology, presentation, and diagnosis of rectal cancer and highlights the interprofessional team's role in its management.

UAN: JA0007034-9999-21-2699-H01-P

Target Audience

This activity has been designed to meet the educational needs of pharmacists.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the etiology of rectal cancer.
  • Review the workup of rectal cancer.
  • Outline the treatment and management options available for rectal cancer.
  • Explain the interprofessional team strategies for improving care coordination and improve outcomes in patients with rectal cancer.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Author(s) / Contributors Disclosure of Conflicts of Interest

Each author, editor, faculty and planning committee member have completed a disclosure form indicating that neither they nor their spouse/partner has a financial interest/arrangement or affiliation that could be perceived as a real or apparent conflict of interest related to the content of this activity.

COMMERCIAL SUPPORT: This activity has received NO commercial support.

Contributors

Hover over the contributor names to see details and disclosures of any financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity.

Continuing Education Accreditation Information


 

 

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare. This activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare, and StatPearls Publishing, LLC.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and StatPearls Publishing, LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.25 contact hours for pharmacists.

FL Board of Pharmacy Tripartite, approval #20-608156.

Cancellation Policy: Cancellations must be received in writing and a money-back guarantee is provided if not completely satisfied.

  • StatPearls and AKH reserve the right to cancel any course due to unforeseen circumstances. StatPearls and AKH will not be responsible for other expenses incurred by the participant in the unlikely event that the program is canceled.

Equal Opportunity

  • StatPearls and AKH are Equal Opportunity / Affirmative Action / Equal Access Institutions. 

Medium or Media Used:

  • Computer Requirements:  Internet Access
  • E-mail Address

Instructions for Credit

  1. Register for the activity and create a StatPearls login.     
  2. Review the required accreditation information:  Target audience, learning objectives, and disclosure information.
  3. Complete the entire self-study activity.
  4. Complete the post-test assessments.
  5. Successfully pass the post-test with a minimum score of 100%.
  6. Complete the evaluation form.

StatPearls and AKH adhere to provider standards regarding commercial support of continuing education. It is the policy of StatPearls and AKH that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved and also that authors and editors will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made prior to starting the activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

  • If you have concerns regarding the CE system, please contact support@statpearls.com, or call 727-289-9796.
  • If you have concerns regarding CE, please contact service@akhcme.com or call AKH 877-AKH-CME4.

 

Media Usage Rights

The contributors and editors of StatPearls have attested that all associated media (images and video) have been legally cleared for use with this activity.  All copyrights are reserved.

    Unlimited Pharmacist CE

    Stay up to date on the latest medical knowledge with 3356 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 3770 hours of CE.

    Single Activity

    Take this single activity

    $19 1 activity

    6 Month Unlimited Pharmacist CE

    Access to all the Unlimited Pharmacist CE activities in all specialties.

    $59 per half year per user

    1 Year Unlimited Pharmacist CE

    Access to all the Unlimited Pharmacist CE activities in all specialties.

    $79 per 1 year per user